-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Pieris Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2023.
- Pieris Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$3.59M, a 190% decline year-over-year.
- Pieris Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$23.8M, a 11.9% increase year-over-year.
- Pieris Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$24.5M, a 26.2% increase from 2022.
- Pieris Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$33.3M, a 27.2% increase from 2021.
- Pieris Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$45.7M, a 22.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)